Attached files
file | filename |
---|---|
EX-99 - EXHIBIT 99.1 - CALYPTE BIOMEDICAL CORP | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 14, 2014
Calypte Biomedical Corporation
(Exact name of registrant as specified in its charter)
Delaware |
000-20985 |
06-1226727 |
(State or other jurisdiction) |
(Commission File Number) |
(I.R.S. Employer Identification) |
of Incorporation) |
|
|
15875 SW 72nd Ave, Portland, OR 97224
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (503) 726-2227
N/A
(Former name or former address, if changed since last report)
☐ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 40.13e-4(c)) |
Item 3.03 Material Modification to Rights of Security Holders
On March 14, 2014, the Registrant amended its Restated Certificate of Incorporation to (i) increase the number of authorized shares of Common Stock from 800,000,000 to 2,400,000,000 and (ii) decrease the par value of the Common Stock to $0.005. A copy of the Registrant’s Certificate of Amendment of Restated Certificate of Incorporation is attached hereto as Exhibit 99.1.
Item 5.07 Submission of Matters to a Vote of Security Holders
On March 14, 2014, a special meeting of stockholders was held to consider the amendment of the Registrant’s Restated Certificate of Incorporation described in Item 3.03 above. The stockholders approved the amendment by the following vote:
For |
Against |
Abstain |
Broker Non-Votes |
409,730,480 |
6,250,881 |
577,434 |
0 |
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. |
Description |
99.1 |
Certificate of Amendment of Restated Certificate of Incorporation. |
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 18, 2014
|
Calypte Biomedical Corporation |
| |
|
|
|
|
|
|
|
|
|
By: |
/s/ Adel Karas |
|
|
|
Adel Karas |
|
|
|
President, Chairman of the Board and Chief Executive Officer |
|
3